icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Veropharm posts 1H 2010 Net Profit of 729.4 million roubles.

Veropharm posts 1H 2010 Net Profit of 729.4 million roubles.
Leading Russian pharmaceutical producer Veropharm, has posted a 1H 2010 Net Profit of 729.4 million roubles under IFRS.

The bottom line is up 21.8% on the 1H 2009 Net Profit of 570.3 million roubles, with EBITDA up by 20.9% year on year to 917.7 million roubles, on the back of consolidated sales revenues rising 16.2% year on year to 2.6 billion roubles.

The company attributed the results to an increase in sales of over the counter drugs and prescription drugs and noted that its debt levels were less than 20% of the company’s net assets. 

Dear readers and commenters,

We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.

Sorry for the inconvenience, and looking forward to your future comments,

RT Team.

Podcasts